Persistence of Uropathogenic Escherichia coli in the Face of Multiple Antibiotics

Antimicrobial Agents and Chemotherapy
2010.0

Abstract

Numerous antibiotics have proven to be effective at ameliorating the clinical symptoms of urinary tract infections (UTIs), but recurrent and chronic infections continue to plague many individuals. Most UTIs are caused by strains of uropathogenic Escherichia coli (UPEC), which can form both extra- and intracellular biofilm-like communities within the bladder. UPEC also persist inside host urothelial cells in a more quiescent state, sequestered within late endosomal compartments. Here, we tested a panel of 17 different antibiotics, representing seven distinct functional classes, for their effects on the survival of the reference UPEC isolate UTI89 within both biofilms and host bladder urothelial cells. All but one of the tested antibiotics prevented UTI89 growth in broth culture, and most were at least modestly effective against bacteria present within in vitro-grown biofilms. In contrast, only a few of the antibiotics, including nitrofurantoin and the fluoroquinolones ciprofloxacin and sparfloxacin, were able to eliminate intracellular bacteria in bladder cell culture-based assays. However, in a mouse UTI model system in which these antibiotics reached concentrations in the urine specimens that far exceeded minimal inhibitory doses, UPEC reservoirs in bladder tissues were not effectively eradicated. We conclude that the persistence of UPEC within the bladder, regardless of antibiotic treatments, is likely facilitated by a combination of biofilm formation, entry of UPEC into a quiescent or semiquiescent state within host cells, and the stalwart permeability barrier function associated with the bladder urothelium.

Knowledge Graph

Similar Paper

Persistence of Uropathogenic Escherichia coli in the Face of Multiple Antibiotics
Antimicrobial Agents and Chemotherapy 2010.0
Eradicating uropathogenic Escherichia coli biofilms with a ciprofloxacin–dinitroxide conjugate
MedChemComm 2019.0
PhoU Is a Persistence Switch Involved in Persister Formation and Tolerance to Multiple Antibiotics and Stresses in Escherichia coli
Antimicrobial Agents and Chemotherapy 2007.0
Antiadhesion Therapy for Urinary Tract Infections—A Balanced PK/PD Profile Proved To Be Key for Success
Journal of Medicinal Chemistry 2012.0
FimH Antagonists: Bioisosteres To Improve the in Vitro and in Vivo PK/PD Profile
Journal of Medicinal Chemistry 2015.0
Urine Bactericidal Activity against Escherichia coli Isolates Exhibiting Different Resistance Phenotypes/Genotypes in an In Vitro Pharmacodynamic Model Simulating Urine Concentrations Obtained after Oral Administration of a 400-Milligram Single Dose of Cefditoren-Pivoxil
Antimicrobial Agents and Chemotherapy 2008.0
Impact of Low-Level Resistance to Fluoroquinolones Due to qnrA1 and qnrS1 Genes or a gyrA Mutation on Ciprofloxacin Bactericidal Activity in a Murine Model of Escherichia coli Urinary Tract Infection
Antimicrobial Agents and Chemotherapy 2009.0
Oral Treatment Options for Ambulatory Patients with Urinary Tract Infections Caused by Extended-Spectrum-β-Lactamase-Producing Escherichia coli
Antimicrobial Agents and Chemotherapy 2010.0
The Chromosomal Toxin Gene yafQ Is a Determinant of Multidrug Tolerance for Escherichia coli Growing in a Biofilm
Antimicrobial Agents and Chemotherapy 2009.0
Role of the rapA Gene in Controlling Antibiotic Resistance of Escherichia coli Biofilms
Antimicrobial Agents and Chemotherapy 2007.0